Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle
Authors:
- RajneeshRARajneesh
- Vibhav GautamVibhav Gautam
- Rajiv KumarRKRajiv Kumar
- 14 September 2023
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 9 (10) , 1795-1814
Abstract
Malaria, caused by Plasmodium species, remains a major global health concern, causing millions of deaths annually. While the introduction of the RTS,S vaccine has shown promise, there is a pressing need for more effective vaccines due to the emergence of drug-resistant parasites and insecticide-resistant vectors. However, the complex life cycle and genetic diversity of the parasite, technical obstacles, limited funding, and the impact of the 2019 pandemic have hindered progress in malaria vaccine development. This review focuses on advancements in malaria vaccine development, particularly the ongoing clinical trials targeting antigens from different stages of the Plasmodium life cycle. Additionally, we discuss the rationale, strategies, and challenges associated with vaccine design, aiming to enhance the immune response and protective efficacy of vaccine candidates. A cost-effective and multistage vaccine could hold the key to controlling and eradicating malaria.Keywords
Funding Information
- Indian Council of Medical Research (2020-0680, 2020-9898)
- Banaras Hindu University (21546)
This publication has 198 references indexed in Scilit:
- Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36PLOS ONE, 2013
- In vivo imaging of CD8+T cell-mediated elimination of malaria liver stagesProceedings of the National Academy of Sciences, 2013
- Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunityProceedings of the National Academy of Sciences, 2013
- Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine VectorsMolecular Therapy, 2011
- Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparumNature, 2011
- Superior Antimalarial Immunity after Vaccination with Late Liver Stage-Arresting Genetically Attenuated ParasitesCell Host & Microbe, 2011
- Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleProceedings of the National Academy of Sciences, 2010
- A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliVaccine, 2009
- Comparative genomics of the neglected human malaria parasite Plasmodium vivaxNature, 2008
- Erythrocyte Binding Protein PfRH5 Polymorphisms Determine Species-Specific Pathways of Plasmodium falciparum InvasionCell Host & Microbe, 2008